| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PHAR.1351 |
| P698 | PubMed publication ID | 24734312 |
| P50 | author | Sony Tuteja | Q42654824 |
| P2093 | author name string | LeAnne T Bloedon | |
| Marina Cuchel | |||
| Danielle Duffy | |||
| Rajesh Movva | |||
| Richard L Dunbar | |||
| Ram Gadi | |||
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Microsomal triglyceride transfer protein | Q27863447 | ||
| Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects | Q28207946 | ||
| Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia | Q28282776 | ||
| Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Q29619614 | ||
| Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors | Q34556386 | ||
| Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance | Q34592657 | ||
| Clinical Pharmacokinetics of Atorvastatin | Q35553211 | ||
| Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study | Q36104706 | ||
| MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises? | Q36709542 | ||
| The effect of gemfibrozil on the pharmacokinetics of rosuvastatin | Q40561482 | ||
| Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors | Q42168863 | ||
| Development of a Population Pharmacokinetic Model for Atorvastatin Acid and Its Lactone Metabolite | Q42917105 | ||
| Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers | Q44704645 | ||
| ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. | Q45993642 | ||
| ABCB1 haplotypes differentially affect the pharmacokinetics of the acid and lactone forms of simvastatin and atorvastatin. | Q46111557 | ||
| Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia | Q46573174 | ||
| Comparison of midazolam and simvastatin as cytochrome P450 3A probes. | Q48710487 | ||
| Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects. | Q53595852 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | triglyceride | Q186319 |
| pharmacokinetics | Q323936 | ||
| hypercholesterolemia | Q762713 | ||
| P304 | page(s) | 227-239 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia | |
| P478 | volume | 34 |
| Q89586580 | Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study |
| Q92219039 | Current Treatment of Familial Hypercholesterolaemia |
| Q91944007 | Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous APOC2 Mutation |
| Q93049588 | Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia |
| Q50952184 | Lomitapide for the treatment of hypercholesterolemia. |
| Q38760884 | Lomitapide for use in patients with homozygous familial hypercholesterolemia: a narrative review |
| Q91907110 | Lomitapide: a review of its clinical use, efficacy, and tolerability |
| Q36040683 | Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia |
| Q38528246 | Management of patients with familial hypercholesterolaemia |
| Q38225581 | Microsomal transfer protein (MTP) inhibition-a novel approach to the treatment of homozygous hypercholesterolemia. |
| Q38839105 | Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism. |
| Q48526234 | Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs. |
| Q26741705 | Unmet Needs in LDL-C Lowering: When Statins Won't Do! |
Search more.